Science Explorer Back to mapMap
Discussion
Company · Rockville · United States

Regenxbio (United States)

regenxbio.comROR OpenAlex
Research works
61
▲ 27% vs 2018-21
Citations
791
13.0 per fractional work
Top-10% rate
11.4%
all institutions 10.0%
Open access
46%
world 40%
International
20%
world 18%
Regenxbio (United States)

Not ranked overall: Regenxbio (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does Regenxbio (United States) work in?

In 2022-now, 50% of research at Regenxbio (United States) is in Life Sciences, 33% in Health Sciences. Its largest fields are Biochemistry, Genetics and Molecular Biology (45%), Medicine (32%), Social Sciences (3%). It does 2.6× the world's share of Life Sciences.

Life Sciences: 15 fractional works · 50.5% of its workBiochemistry, Genetics and Molecular Biology: 14 fractional works · 45.4% of its workMolecular Biology: 7 fractional works · 24.5% of its workGenetics: 5 fractional works · 18.0% of its workCell Biology: 0 fractional works · 1.6% of its workPhysiology: 0 fractional works · 0.6% of its workCancer Research: 0 fractional works · 0.6% of its workNeuroscience: 1 fractional works · 2.9% of its workCellular and Molecular Neuroscience: 1 fractional works · 1.9% of its workNeurology: 0 fractional works · 0.6% of its workDevelopmental Neuroscience: 0 fractional works · 0.4% of its workAgricultural and Biological Sciences: 0 fractional works · 1.7% of its workAnimal Science and Zoology: 0 fractional works · 1.1% of its workEcology, Evolution, Behavior and Systematics: 0 fractional works · 0.6% of its workImmunology and Microbiology: 0 fractional works · 0.5% of its workImmunology: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.2% of its workHealth Sciences: 10 fractional works · 33.4% of its workMedicine: 10 fractional works · 32.3% of its workPhysiology: 4 fractional works · 12.6% of its workEpidemiology: 1 fractional works · 3.7% of its workInfectious Diseases: 1 fractional works · 3.4% of its workRheumatology: 1 fractional works · 1.9% of its workGenetics: 1 fractional works · 1.8% of its workRadiology, Nuclear Medicine and Imaging: 0 fractional works · 1.6% of its workPediatrics, Perinatology and Child Health: 0 fractional works · 1.6% of its workOphthalmology: 0 fractional works · 1.2% of its workNephrology: 0 fractional works · 1.1% of its workPathology and Forensic Medicine: 0 fractional works · 0.6% of its workSurgery: 0 fractional works · 0.6% of its workOncology: 0 fractional works · 0.5% of its workPsychiatry and Mental health: 0 fractional works · 0.5% of its workCardiology and Cardiovascular Medicine: 0 fractional works · 0.4% of its workNeurology: 0 fractional works · 0.4% of its workHematology: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.2% of its workHealth Professions: 0 fractional works · 1.1% of its workPharmacy: 0 fractional works · 1.1% of its workSocial Sciences: 3 fractional works · 8.8% of its workSocial Sciences: 1 fractional works · 3.4% of its workEducation: 1 fractional works · 3.4% of its workPsychology: 1 fractional works · 2.2% of its workDevelopmental and Educational Psychology: 1 fractional works · 2.2% of its workEconomics, Econometrics and Finance: 1 fractional works · 2.0% of its workFinance: 0 fractional works · 1.1% of its workEconomics and Econometrics: 0 fractional works · 0.9% of its workDecision Sciences: 0 fractional works · 1.1% of its workManagement Science and Operations Research: 0 fractional works · 1.1% of its workPhysical Sciences: 2 fractional works · 7.4% of its workEngineering: 1 fractional works · 2.1% of its workBiomedical Engineering: 1 fractional works · 1.9% of its workElectrical and Electronic Engineering: 0 fractional works · 0.2% of its workMathematics: 1 fractional works · 1.7% of its workStatistics and Probability: 1 fractional works · 1.7% of its workEnvironmental Science: 0 fractional works · 1.1% of its workEcology: 0 fractional works · 1.1% of its workMaterials Science: 0 fractional works · 1.1% of its workBiomaterials: 0 fractional works · 1.1% of its workChemistry: 0 fractional works · 0.7% of its workSpectroscopy: 0 fractional works · 0.7% of its workComputer Science: 0 fractional works · 0.6% of its workComputational Theory and Mathematics: 0 fractional works · 0.6% of its workALL ITS WORKRegenxbio (UnitedStates)30fractional works, 2022-now
Life Sciences50%Physical Sciences7%Health Sciences33%Social Sciences9%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in 2022-now. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 16 fields, with their numbers
    1. Biochemistry, Genetics and Molecular Biology1445.4%
    2. Neuroscience12.9%
    3. Agricultural and Biological Sciences01.7%
    4. Immunology and Microbiology00.5%
    1. Medicine1032.3%
    2. Health Professions01.1%
    1. Social Sciences13.4%
    2. Psychology12.2%
    3. Economics, Econometrics and Finance12.0%
    4. Decision Sciences01.1%
    1. Engineering12.1%
    2. Mathematics11.7%
    3. Environmental Science01.1%
    4. Materials Science01.1%
    5. Chemistry00.7%
    6. Computer Science00.6%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.35× its world share, 0 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 8.51× its world share, 14 worksBiochemistry, Geneti…Immunology and Microbiology: 0.52× its world share, 0 worksImmunology and Micro…Neuroscience: 1.78× its world share, 1 worksNeuroscienceChemistry: 0.47× its world share, 0 worksChemistryComputer Science: 0.07× its world share, 0 worksComputer ScienceEngineering: 0.14× its world share, 1 worksEngineeringEnvironmental Science: 0.22× its world share, 0 worksEnvironmental ScienceMaterials Science: 0.32× its world share, 0 worksMaterials ScienceMathematics: 1.46× its world share, 0 worksMathematicsHealth Professions: 0.42× its world share, 0 worksHealth ProfessionsMedicine: 1.68× its world share, 10 worksMedicineDecision Sciences: 1.16× its world share, 0 worksDecision SciencesEconomics, Econometrics and Finance: 0.96× its world share, 1 worksEconomics, Econometr…Psychology: 0.73× its world share, 1 worksPsychologySocial Sciences: 0.26× its world share, 1 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Biochemistry, Genetics and Molecular Biology, 8.5×. Every wedge is a field page.

All 16 fields, with their numbers
  1. Biochemistry, Genetics and Molecular Biology8.51×14 works
  2. Neuroscience1.78×1 works
  3. Medicine1.68×10 works
  4. Mathematics1.46×0 works
  5. Decision Sciences1.16×0 works
  6. Economics, Econometrics and Finance0.96×1 works
  7. Psychology0.73×1 works
  8. Immunology and Microbiology0.52×0 works
  9. Chemistry0.47×0 works
  10. Health Professions0.42×0 works
  11. Agricultural and Biological Sciences0.35×0 works
  12. Materials Science0.32×0 works
  13. Social Sciences0.26×1 works
  14. Environmental Science0.22×0 works
  15. Engineering0.14×1 works
  16. Computer Science0.07×0 works

Who are the top researchers at Regenxbio (United States)?

Ranked on the quality score, Karen Kozarsky, Nicholas A. P. S. Buss and Francesca Cook lead among researchers whose main affiliation is Regenxbio (United States).

  1. 1 Karen Kozarsky United States · #789,293 worldwide 8.8k citations · 99 works
  2. 2 Nicholas A. P. S. Buss United States · #1,840,129 worldwide 1.1k citations · 53 works
  3. 3 Francesca Cook United States · #2,054,680 worldwide 368 citations · 16 works
  4. 4 Yoonjin Cho United States · #2,508,846 worldwide 613 citations · 37 works
  5. 5 Dawn Phillips United States · #2,725,159 worldwide 1.2k citations · 87 works
  6. 6 Marie-Laure Névoret United States · #3,318,676 worldwide 912 citations · 62 works
  7. 7 Therese Conner United States · #4,854,430 worldwide 277 citations · 23 works
  8. 8 Vivian Fernandez United States · #5,112,859 worldwide 155 citations · 25 works
All ranked researchers at Regenxbio (United States)

What are the most cited papers from Regenxbio (United States)?

The most cited paper from Regenxbio (United States) is "Anifrolumab, an Anti–Interferon‐α Receptor Monoclonal Antibody, in Moderate‐to‐Severe Systemic Lupus Erythematosus" (Richard Alan Furie, Munther A. Khamashta, Joan T. Merrill et al., 2016), with 884 citations. Next come "Preclinical and clinical evaluation of the LRRK2 inhibitor DNL201 for Parkinson’s disease" (266) and "AAV8-vectored suprachoroidal gene transfer produces widespread ocular transgene expression" (141).

Most cited papers
#PaperReleasedCitations
1 Anifrolumab, an Anti–Interferon‐α Receptor Monoclonal Antibody, in Moderate‐to‐Severe Systemic Lupus Erythematosus Richard Alan Furie, Munther A. Khamashta, Joan T. Merrill et al. · Arthritis & Rheumatology Open access 7 Nov 2016 884
2 Preclinical and clinical evaluation of the LRRK2 inhibitor DNL201 for Parkinson’s disease Danna L. Jennings et al. · Science Translational Medicine 8 Jun 2022 266
3 AAV8-vectored suprachoroidal gene transfer produces widespread ocular transgene expression Kun Ding, Jikui Shen, Zibran Hafiz et al. · Journal of Clinical Investigation Open access 13 Aug 2019 141
4 Gene therapy for neovascular age-related macular degeneration by subretinal delivery of RGX-314: a phase 1/2a dose-escalation study Peter A. Campochiaro, Robert L. Avery, David M. Brown et al. · The Lancet 27 Mar 2024 129
5 Addressing the Value of Gene Therapy and Enhancing Patient Access to Transformative Treatments Rachel Salzman, Francesca Cook, Timothy D. Hunt et al. · Molecular Therapy Open access 29 Oct 2018 115
All 61 most cited papers, with filters and sorting

Which keywords describe research at Regenxbio (United States)?

By fractional works in 2022-now, weighted toward what it does more of than the world: Gene Therapy, Genomic Integration, AAV, Viral Vectors, Parkinson's Disease, Enzyme Replacement Therapy, Lysosomal Storage Disorders and Stem Cells.

▲ more of its work than of the world's◆ about the world's share▼ less than the world's

Size is fractional works in 2022-now in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 26 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 26 words, with their numbers
  1. Gene Therapy6▲ 101×3 topics
  2. Genomic Integration4▲ 252×2 topics
  3. AAV4▲ 357×1 topic
  4. Viral Vectors4▲ 357×1 topic
  5. Enzyme Replacement Therapy3▲ 551×1 topic
  6. Lysosomal Storage Disorders3▲ 683×1 topic
  7. Parkinson's Disease3▲ 42×2 topics
  8. Epidemiology3▲ 2.3×8 topics
  9. Stem Cells2▲ 23×2 topics
  10. Genome Engineering2▲ 90×1 topic
  11. Muscle Regeneration2▲ 209×1 topic
  12. RNA-Guided2▲ 90×1 topic
  13. Skeletal Muscle Atrophy2▲ 209×1 topic
  14. Pathogenesis2▲ 9.8×3 topics
  15. Vaccine2▲ 13×4 topics
  16. Child Development1▲ 11×2 topics
  17. RNA Interference1▲ 52×1 topic
  18. siRNA Delivery1▲ 74×1 topic
  19. Cell Culture1▲ 35×2 topics
  20. Regenerative Medicine1▲ 16×3 topics
  21. Infection1▲ 15×2 topics
  22. Glycosylation1▲ 32×2 topics
  23. Norovirus1▲ 80×1 topic
  24. Rotavirus1▲ 80×1 topic
  25. School Engagement1▲ 72×1 topic
  26. Student-Teacher Relationships1▲ 72×1 topic

Which research topics does Regenxbio (United States) publish most on?

By volume in 2022-now: Virus-based gene therapy research, Lysosomal Storage Disorders Research, Muscle Physiology and Disorders and CRISPR and Genetic Engineering.

Virus-based gene therapy…4Virus-based gene therapy research: 4 fractional worksLysosomal Storage Disorders Research: 3 fractional worksMuscle Physiology and Disorders: 2 fractional worksCRISPR and Genetic Engineering: 2 fractional worksRNA Interference and Gene Delivery: 1 fractional worksEarly Childhood Educatio…1Early Childhood Education and Development: 1 fractional worksViral gastroenteritis research and epidemiology: 1 fractional worksViral Infectious Diseases and Gene Expression in Insects: 1 fractional worksTrypanosoma species research and implications: 1 fractional worksBiomedical Ethics and Regulation: 1 fractional works
GeneticsPhysiologyMolecular BiologyEducation2 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Virus-based gene therapy research Genetics 4 works
  2. 2 Lysosomal Storage Disorders Research Physiology 3 works
  3. 3 Muscle Physiology and Disorders Molecular Biology 2 works
  4. 4 CRISPR and Genetic Engineering Molecular Biology 2 works
  5. 5 RNA Interference and Gene Delivery Molecular Biology 1 works
  6. 6 Early Childhood Education and Development Education 1 works
  7. 7 Viral gastroenteritis research and epidemiology Infectious Diseases 1 works
  8. 8 Viral Infectious Diseases and Gene Expression in Insects Molecular Biology 1 works
  9. 9 Trypanosoma species research and implications Epidemiology 1 works
  10. 10 Biomedical Ethics and Regulation Physiology 1 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available45.6%not open54.4%

World: 40% of research is openly available.

with international co-authors20.1%domestic only79.9%

World: 18% is written across borders.

How has Regenxbio (United States)'s research output changed?

Output in 2022-2025 was 27% higher than in 2018-2021.

still counting200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Regenxbio (United States) as a percentage of every work published that year, 0.00014% in 2024.

still counting0.00010%0.00020%0.00030%Regenxbio (United States)0.000052% in 2025200020102020

Fractional works of Regenxbio (United States) over all fractional works that year. How the balance of science has shifted.

Other research institutions in Rockville

All research institutions in Rockville

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Regenxbio (United States). Posts are plain text and can be reported.